3. Delirium‐ and coma‐free days: league table of posterior median pairwise RoM and 95% (lower triangle), and pairwise probabilities that a treatment is better than another (upper triangle).

Atypical antipsychotic	0.784	0.854	0.898
1.15 (0.58, 2.40)	Typical antipsychotic	0.768	0.781
1.46 (0.45, 5.41)	1.27 (0.40, 4.30)	Statin	0.340
1.31 (0.69, 2.83)	1.14 (0.64, 2.16)	0.90 (0.32, 2.52)	Placebo

RoM: ratio of means.

A complete summary of estimates for efficacy from the random‐effects (RE) consistency model assuming vague priors is displayed.

Treatments other than placebo are in the order of decreasing surface under the cumulative ranking curve (SUCRA) value from upper left to lower right. For each comparison, the lower/right‐most treatment is the reference treatment. For example, the RoM estimate of 1.31 (95% credible interval (CrI) 0.69 to 2.83) in the lower triangle suggests a 31% increase in mean delirium‐ and coma‐free days with atypical antipsychotics compared to placebo. The corresponding probability estimate in the upper triangle suggests a probability of 89.8% that atypical antipsychotics are better than placebo in terms of delirium‐ and coma‐free days.